$CTLT (Catalent, Inc.)

$CTLT {{ '2016-08-29T20:38:03+0000' | timeago}} • Announcement

For FY17, $CTLT expects revenue in the range of $1.920-1.995Bil, adjusted EBITDA to be between $430-455MM and adjusted net Income to be between $165-190MM. These ranges are consistent with the organic, constant currency long-term CAGR growth expectations of 4-6% for revenue and 6-8% for adjusted EBITDA. CapEx is expected to be $125-135MM for FY17.

$DXC {{ '2017-07-05T13:22:08+0000' | timeago}} • Announcement

$DXC has acquired Tribridge, an independent integrators of Microsoft Dynamics 365. The acquisition includes the Tribridge affiliate company, Concerto Cloud Services. Under the agreement, which is effective immediately, Tribridge will be known as Tribridge, a DXC Technology Company. Financial terms were not disclosed.

$XPER {{ '2017-07-05T13:11:54+0000' | timeago}} • Announcement

$XPER business Tessera Technologies said the US International Trade Commission has issued a favorable order on the company’s patent infringement dispute with $BRCM. Tessera’s counsel has confirmed the broad scope of the company’s victory in the lawsuit, related mainly to infringement of patents of semiconductor chips.

$LCII {{ '2017-07-03T14:37:19+0000' | timeago}} • Announcement

Engineering firm $LCII said its Lippert Components units acquired Italy-based Metallarte and its subsidiary RV Doors, a manufacturer of driver-side doors. The $16.8MM purchase price was paid from available cash, borrowings under the company's $200MM line of credit and contingent consideration based on future sales.

$AOBC {{ '2017-06-30T13:55:31+0000' | timeago}} • Webcast

$AOBC said its internal inventory levels were slightly elevated in 4Q17, mainly in firearms, and the Smith & Wesson maker expects those levels to continue rising over the next several months building inventory for the fall hunting and holiday season.

$AOBC {{ '2017-06-30T13:44:51+0000' | timeago}} • Webcast

As $AOBC posted 4Q17 results, the company said, "we expect the seasonal impact on our revenue to be much more pronounced in the first-half of fiscal 2018"

$AOBC {{ '2017-06-30T13:37:56+0000' | timeago}} • Webcast

Regarding $AOBC's 500,000-square foot distribution center in Missouri, construction expected to take at least 18 months and the entire project requiring two to three years to complete, the company announced as it posted 4Q17 results.

$AOBC {{ '2017-06-29T20:34:15+0000' | timeago}} • Infographic

$AOBC American Outdoor Brands Corporation Earnings AlphaGraphic: Q4 2017 Highlights

$AOBC {{ '2017-06-29T20:28:56+0000' | timeago}} • Announcement

In FY18, $AOBC expects to continue employing strength of its balance sheet, including unused portion of its revolving line of credit, which is expandable up to $500MM, to fuel additional growth opportunities, both organic and inorganic.

$AOBC {{ '2017-06-29T20:27:11+0000' | timeago}} • Announcement

$AOBC expects 1Q18 net sales of $140-150MM, EPS of $0.01-0.06 and non-GAAP EPS of $0.07-0.12. For the full year 2018, the company predicts net sales of $750-790MM, EPS of $1.16-1.36 and non-GAAP EPS of $1.42-1.62.

$AOBC {{ '2017-06-29T20:25:15+0000' | timeago}} • Announcement

$AOBC reported a drop in 4Q17 earnings due to higher costs and expenses. Net income fell to $27.69MM or $0.50 per share from $35.65MM or $0.63 per share last year. Net sales grew to $229.19MM from $221.12MM, on growth in its Firearms and Outdoor products and accessories segments. Non-GAAP EPS decreased to $0.57 from $0.66.

$AMRI {{ '2017-06-29T13:20:42+0000' | timeago}} • Announcement

$AMRI announced the early termination of waiting period, in connection with its proposed acquisition by affiliates of $CG and GTCR LLC.  The early termination of the HSR waiting period satisfies one of the conditions to the proposed acquisition, valued $21.75 per share in cash.  The merger is expected to close in 3Q17.

$BIVV {{ '2017-06-28T20:37:42+0000' | timeago}} • Announcement

$BIVV successfully closed its acquisition of True North Therapeutics, a privately-held, clinical-stage rare disease biotechnology company. The acquisition advances $BIVV's vision of becoming the leading rare disease company focused on blood disorders.

$FTI {{ '2017-06-13T21:48:54+0000' | timeago}} • Announcement

$FTI received an extension to its ongoing Engineering, Procurement and Construction (EPC) contract from Statoil in the Norwegian North Sea. The project will be executed as an integrated Engineering, Procurement, Construction and Installation (iEPCI).

$BIVV {{ '2017-06-12T14:42:33+0000' | timeago}} • Announcement

Biotech firm $BIVV said the FDA has accepted its investigational new drug application for BIVV001, a novel therapy for extending protection from bleeds in people with hemophilia A. BIVV001 is the only investigational factor-VIII therapy in development that is designed to overcome the von Willebrand factor ceiling.

$HOME {{ '2017-06-07T13:56:02+0000' | timeago}} • Infographic

$HOME At Home Group Inc. Earnings AlphaGraphic: Q1 2018 Highlights

$FTI {{ '2017-06-07T13:30:07+0000' | timeago}} • Announcement

$FTI entered into a 3-year frame agreement with Woodside Energy Ltd in Australia for Riserless Light Well Intervention (RLWI) and subsea services. $FTI will install subsea trees and deploy its deepwater RLWI stack to perform well intervention services on up to eight subsea wells in the GWF-2 development.

$HOME {{ '2017-06-07T12:24:03+0000' | timeago}} • Announcement

$HOME has raised its sales outlook for fiscal 2018 to the range of $906-913MM, representing a 18-19% growth. Comparable store sales are seen increasing around 3%. Net profit is forecasted to be $39.4-41.0MM, and EPS between $0.62 and $0.64. $HOME increased the midpoint of its adjusted EPS and now the EPS is expected at $0.73-0.75.

$HOME {{ '2017-06-07T12:08:08+0000' | timeago}} • Announcement

Retail chain $HOME reported a 37% annual growth in 1Q18 profit to $10MM, due to higher sales. Earnings per share rose to $0.16 from $0.14 last year. On an adjusted basis, profit and EPS increased 32% and 27% YoY respectively. Net sales surged 23% to $211.84MM, helped by the addition of 23 new stores and a 5.8% gain in comparable store sales.

$AMRI {{ '2017-06-06T11:56:53+0000' | timeago}} • Announcement

$AMRI signed a definitive agreement to be acquired by affiliates of $CG and GTCR LLC for $21.75 per share in cash. The transaction will be financed through a combination of debt and equity financing. Carlyle and GTCR have received debt financing commitments to finance the transaction.

$XPER {{ '2017-06-02T13:40:02+0000' | timeago}} • Announcement

Invensas Corp., a subsidiary of $XPER, said a German appellate court denied $AVGO and Broadcom Corp.'s motion to stay enforcement of a patent infringement judgment that a German district court recently entered against Broadcom.

Recent Transcripts

AOBC (American Outdoor Brands Corporation)
Thursday, June 29 2017 - 9:00pm
HOME (At Home Group Inc.)
Wednesday, June 7 2017 - 12:30pm
DXC (DXC Technology Company)
Thursday, May 25 2017 - 9:00pm
RDY (Dr. Reddy's Laboratories Ltd.)
Friday, May 12 2017 - 12:30pm
AMRI (Albany Molecular Research Inc.)
Tuesday, May 9 2017 - 12:30pm
SRCI (SRC Energy Inc.)
Friday, May 5 2017 - 3:00pm
VREX (Varex Imaging Corporation)
Thursday, May 4 2017 - 9:00pm
CTLT (Catalent, Inc.)
Thursday, May 4 2017 - 8:45pm
LCII (LCI Industries)
Thursday, May 4 2017 - 3:00pm
BIVV (Bioverativ Inc.)
Thursday, May 4 2017 - 12:00pm
XPER (Xperi Corporation)
Wednesday, May 3 2017 - 9:00pm
CAH (Cardinal Health, Inc.)
Monday, May 1 2017 - 12:30pm
TVTY (Tivity Health, Inc.)
Thursday, April 27 2017 - 9:00pm
FTI (TechnipFMC plc)
Thursday, April 27 2017 - 12:00pm
AMRI (Albany Molecular Research Inc.)
Tuesday, February 21 2017 - 1:30pm
CAH (Cardinal Health, Inc.)
Tuesday, February 7 2017 - 1:30pm
CTLT (Catalent, Inc.)
Monday, February 6 2017 - 9:45pm
AMRI (Albany Molecular Research Inc.)
Tuesday, November 8 2016 - 1:30pm
CTLT (Catalent, Inc.)
Monday, November 7 2016 - 9:45pm
CAH (Cardinal Health, Inc.)
Monday, October 31 2016 - 12:30pm

AlphaGraphics you may like